John Nolan - Concepedia

Author

John Nolan

Devon History Society ORCID

Also Known As

J Nolan, J. C. NOLAN, J. C. Nolan, J. Nolan, J.C. Nolan, John C. Nolan, John Nolan, Nolan, John Christopher

Publications

964

Citations

H-Index

Concepts

All Affiliations

Devon History Society Royal College of Surgeons in Ireland Mount Vernon Hospital University of Manchester Children's Health Ireland at Crumlin

About

John Nolan is an author at Devon History Society specializing in medicine, pharmacology, and oxidative stress.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	621
2	Biochemistry	4	4	93
3	Cell Biology	3	3	343
4	Engineering	1	1	22
5	Natural Sciences	1	1	21

John Nolan

Publications

883

Citations

H-Index

Page 1

	Year	Citations
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Peter D. Davis, Graeme J. Dougherty, David C. Blakey, Oxford University Research Archive (ORA) (University of Oxford) Endothelial Cell MorphologyChemoprevention StrategyTumor BiologyNovel Vascular-targeting AgentAngiogenesis	2002	231
The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro Olga Piskareva, Harry Harvey, John Nolan, Cancer Letters Cisplatin ResistanceCross ResistanceDevelopmental BiologyGliomaMedicine	2015	90
Indolequinone Antitumor Agents: Reductive Activation and Elimination from (5-Methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl Derivatives and Hypoxia-Selective Cytotoxicity in Vitro Matthew A. Naylor, Elizabeth Swann, Steven A. Everett, Journal of Medicinal Chemistry	1998	69
A physiologically relevant 3D collagen-based scaffold–neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models Caroline M. Curtin, John Nolan, Ronald A. Conlon, Acta Biomaterialia	2018	62
Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine Adams Ge, J. Godden, John Nolan, British Journal of Cancer Pharmaceutical ScienceMedicineAnti-tumour EffectPharmacotherapyAnti-cancer Agent	1988	59
2-Cyclopropylindoloquinones and Their Analogues as Bioreductively Activated Antitumor Agents: Structure−Activity <i>in Vitro</i> and Efficacy <i>in Vivo</i> Matthew A. Naylor, Mohammed Jaffar, John Nolan, Journal of Medicinal Chemistry	1997	51
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD Kaitlin J. Mayne, Natalie Staplin, David Keane, Journal of the American Society of Nephrology	2023	40
The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions Mark Saunders, Mohammed Jaffar, Adam V. Patterson, Biochemical Pharmacology Reductive StressAldo-keto ReductaseBiochemistryMedicineRelative Importance	2000	36
A Context-Dependent Role for MiR-124-3p on Cell Phenotype, Viability and Chemosensitivity in Neuroblastoma in vitro John Nolan, Manuela Salvucci, Steven Carberry, Frontiers in Cell and Developmental Biology	2020	26
NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radiolabelled misonidazole LM Cobb, Terry Hacker, John Nolan British Journal of Cancer Normoxic TissuesAldo-keto ReductaseBiochemistryReactive Nitrogen SpecieMedicine	1990	24

Page 1